A court in eastern France sentenced former anaesthetist Frédéric Péchier to life imprisonment on Thursday after he was found guilty of poisoning 30 patients, 12 of them fatally. The verdict followed 15 weeks of hearings, with the court taking three days to rule individually on each case.
The offences occurred between 2008 and 2017 in two private clinics in Besançon, affecting patients aged between four and 89. According to the prosecution, Péchier contaminated infusion bags with potassium, local anaesthetics, adrenaline, and heparin in order to induce cardiac arrest or haemorrhage in patients treated by his colleagues.
During the investigation, which began in 2017, Péchier consistently denied involvement. At the start of the trial, he acknowledged that a poisoner had been active in one of the clinics but continued to maintain that he was not responsible.
Court proceedings revealed the extent of the harm caused by the poisonings. Twelve patients died, while 18 survived, some with lasting health consequences. The court evaluated each case individually before delivering the life sentence.
Péchier, 53, reportedly displayed little emotion during much of the trial but became visibly upset on 5 December when discussing a 2021 suicide attempt. His defence lawyer, Randall Schwerdorffer, said that Péchier “has always been in control” and does not typically show his emotions. Schwerdorffer added that his client had underestimated the trial’s difficulty and expected the jury to quickly accept his claims of innocence.
Despite the conviction, Péchier’s lawyer confirmed plans to appeal. Schwerdorffer reiterated his belief in his client’s innocence, stating that legal proceedings would continue in higher courts.
The case drew significant attention in France, both for the severity of the crimes and the prolonged period over which they occurred. Authorities emphasized the challenges involved in detecting deliberate poisoning in medical settings, highlighting the complexity of securing evidence in cases where patients are already vulnerable.
Local and national media reported that the court examined forensic evidence, hospital records, and testimony from colleagues and experts to establish Péchier’s actions. The ruling is expected to have wide-reaching implications for patient safety and oversight in private healthcare facilities.
The Besançon trial underscores the importance of vigilance in medical practices and monitoring of controlled substances, particularly in environments where multiple patients rely on shared protocols and staff. Authorities have indicated that lessons from the case will inform stricter safety procedures and surveillance in clinical settings to prevent similar incidents in the future.
Péchier’s sentencing marks a rare and severe punishment in cases of medical malpractice escalating to deliberate harm, reflecting the judiciary’s determination to hold healthcare professionals accountable for criminal actions that endanger patient lives.
